Moshe N. Gavrielov
Analyst · Credit Suisse
Thank you, Jon, and good afternoon to you all. The 4% sequential sales growth in the March quarter was driven by double-digit increases on 6 of our secondary end markets. This broad-based strength highlights recovery in our business. Revenue was primarily driven by exceptional growth from our 28-nanometer product family, which exceeded $40 million, significantly surpassing our expectations. 28-nanometer sales were driven by both our midrange Kintex-7 and our high-performance Virtex-7 product families. We are now converting technology leadership to revenue growth. 28-nanometer Xilinx is a generation ahead of our competition in 4 areas. We have the broadest portfolio with our all programmable FPGAs, SoCs and 3D ICs. Second, we have the best products with an extra node of performance, lower power, high levels of integration and connectivity with the industry's absolutely best service. Third, and per our customers, critically more importantly, as our average design complexity has skyrocketed, we enable the highest productivity with Vivado, the industry's first SoC-strength tool suite. This enables delivering unmatched time to integration and implementation and, by far, the best quality of results, i.e. higher density, higher performance and lower power. Lastly, we enabled smarter systems with the unique combination of SmartCORE IP, C-based design tools and libraries, embedded software running on our market-defining ARM-based solutions. Leveraging all 4 advantages, revenue growth is already being driven by continued PLD share gains, considerable displacement of ASICs and ASSPs, aggressive market penetration and core target growth driver applications. Smarter 100-gig wired networks, wireless HetNets, data centers, retail and vision-based systems. In the March quarter, we announced multiple industry first, the 20-nanometer, clearly demonstrating between our -- this node to staying a generation ahead. Vivado Tool Suite now supports 20-nanometer designs. We are currently working with numerous Early Access customers. We'll be taping out our first 20-nanometer device this quarter as predicted. The rollout of our 7 Series and Zynq All Programmable SoC product generation is nearly complete with all 5 families in production. Fiscal year 2013, 28-nanometer sales comfortably surpassed $100 million. Over 500 customers receiving shipments in the March quarter alone in a broad base of applications including communications, industrial, defense and broadcast. In the June quarter, we expect our 20-nanometer shipment -- 28-nanometer shipments to, again, exceed $14 million in sales. As we discussed at our Analyst Day last month, we are very confident 28-nanometer sales will grow to more than $250 million in fiscal year 2014. With an improving demand environment, industry's broadest and, by far, best 28-nanometer portfolio, focusing penetration into the highest growth applications and significant progress in displacing ASICs and ASSPs, the new fiscal year promises to be an exciting year for Xilinx, here, where we will clearly connect technology leadership to revenue and demonstrate we're a generation ahead for accelerated growth. Let me now turn the call back to the operator to open it up for the Q&A session.